# Cohort Study of Patients With HER2-negative MBC and BRCA 1/2 Pathogenic Mutation

> **NCT04368442** · — · UNKNOWN · sponsor: **Samsung Medical Center** · enrollment: 583 (estimated)

## Conditions studied

- Breast Cancer Metastatic

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04368442
- **Lead sponsor:** Samsung Medical Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-10-17
- **Primary completion:** 2020-12-31
- **Final completion:** 2021-12-31
- **Target enrollment:** 583 (ESTIMATED)
- **Last updated:** 2020-04-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04368442

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04368442, "Cohort Study of Patients With HER2-negative MBC and BRCA 1/2 Pathogenic Mutation". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04368442. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*